CEP-37250/KHK2804
CEP-37250/KHK2804-001
Phase 1 small_molecule completed
Quick answer
CEP-37250/KHK2804 for Solid Tumour is a Phase 1 program (small_molecule) at Teva Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Teva Pharma GmbH
- Indication
- Solid Tumour
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed